baber/WOPTO huggingface dataset:
Patent PT-2062977-E (PT)
Title: Fucosyltransferase-gene
Inventor: ALTMANN FRIEDRICH
IPC: C12N15/11
Filed: 2000-02-17
Abstract: A DNA molecule (I), encoding a plant protein with fucosyl transferase activity, comprising a 2198 base pair sequence, fully defined in the specification, with an open reading frame of nucleotides 211-1740, a sequence at least 50 % homologous to it, a sequence hybridizing to it under stringent conditions, a sequence which differs due to genetic code degeneracy, or their complement, is new. Independent claims are also included for the following: (1) a DNA molecule (II), comprising a 105 base pair sequence, fully defined in the specification, a sequence at least 95 % homologous to it, a sequence that hybridizes to it under stringent conditions, or a sequence which differs due to genetic code degeneracy; (2) a DNA molecule which is a partial sequence of (I) or (II), which comprises 30-50 base pairs; (3) (I) or (II) covalently associated with a detectable marker substance; (4) a biologically functional vector comprising (I) or (II) or a partial sequence of at least 20 base pairs; (5) a biologically functional vector comprising (I), (II) or a partial sequence in inverse orientation to the promoter; (6) (I), (II) or the DNA molecule of (2) or (3) comprising a deletion, insertion and/or substitution mutation; (7) a DNA encoding a ribozyme, which comprises two sequence sections of at least 10-15 base pairs, which are complementary to (I) or (II), so that the ribozyme complexes with and cuts the mRNA, which is transcribed from a natural GlcNAc-alpha 1,3-fucosyl transferase DNA molecule; (8) a biologically functional vector comprising DNA of (6) or (7); (9) producing a cDNA of (I) or (II) comprising isolating RNA of insects or plants, and carrying out reverse transcription with a reverse transcriptase and primers; (10) cloning a GlcNAc-alpha 1,3-fucosyl transferase; (11) producing recombinant host cells which over-express GlcNAc-alpha 1,3-fucosyltransferase; (12) producing recombinant host cells, preferably plant or insect cells, which have a DNA of (6) in place of the non-mutated homologous sequence; (13) a recombinant plant or insect cell produced by the method of (12) and which over-expresses the GlcNAc-alpha 1,3-fucosyltransferase; (14) a PNA (peptide-nucleic acid) molecule which is complementary to or the same as (I); (15) producing a plant or insect cell with blocked GlcNAc-alpha 1,3-fucosyl transferase expression at the level of transcription or translation by the PNA of (14); (16) a method of recombinant glycoprotein production; (17) a recombinant glycoprotein produced in a plant or insect cell system as above; a GlcNAc-alpha 1,3-fucosyltransferase preparation, cloned by a method of (16), where the isoforms have a pI of between 6 and 9, preferably 6.8 and 8.2; and (18) producing human and other vertebrate carbohydrates by transplantation.
Patent PT-2342954-E (PT)
Title: Electrical circuit configuration having overlapping capacitances
Inventor: FLUHRER CHRISTOPH
IPC: H01L23/498
Filed: 2009-09-01
Abstract: The invention relates to an electrical low-pass filter circuit configuration, comprising a substrate (24) and at least four conductive surfaces (20, 21, 22, 23). At least two of the at least four conductive surfaces (22, 23) are disposed on the surface of two different sides of the substrate (24) and form a capacitance and an inductance. At least two further conductive surfaces (20, 21) are disposed at different sides of the substrate (24) and form one capacitance each with at least the conductive surface (22, 23) disposed on the surface of each side of the substrate (24).
Patent PT-594001-E (PT)
Inventor: TOMER JOHN DICK
IPC: A61P25/24
Filed: 1993-10-08
Abstract: The invention relates to compounds of the frmula <CHEM>  wherein     Ar is <CHEM>  or pyridyl;     R1 is H,-(CH2)pNR2R3, <CHEM>     R2 is hydrogen or loweralkyl;     R3 is hydrogen or loweralkyl;     R4 is hydrogen or loweralkyl; X and Y are independently halogen, trifluoromethyl, nitro, loweralkyl, loweralkoxy or hydroxy;     n is 0, 1, 2 or 3;     m is 0, 1 or 2;     p and q are independently 2, 3 or 4; or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof. This invention also relates to a process for making the compounds and to pharmaceutical compositions, and to their use as serotonin reuptake inhibitors.
Patent PT-659408-E (PT)
Inventor: ULRICH HEINZ
IPC: A61K31/19
Filed: 1994-12-17
Abstract: Use of (R+)-alpha-liponic acid (I), R(-)-dihydroliponic acid (II) or their metabolites, salts, esters or amides for prodn. of medicaments for treating the following conditions is new: (1) type I diabetes mellitus; (2) type II diabetes mellitus; (3) compensated and decompensated insulin resistance; (4) sequelae or complications of diabetes mellitus, e.g. cataracts, polyneuropathy or nephropathy; (5) sequelae or complications of insulin resistance; and (6) disorders associated with limited glucose transport protein (GTP) function or reduced GTP levels. Also claimed are: (a) the medicaments of (1)-(5) in combination with other antidiabetic agents, esp. insulin; and (b) the medicaments of (1)-(6) contg. vitamin E, vitamin C, NADH, NADPH and/or ubiquinones as additives or stabilisers.
Patent PT-677249-E (PT)
Inventor: KWON STEREN SOON-YOUNG
IPC: A23L27/21
Filed: 1995-03-02
Abstract: A process for enhancing the salty taste of a food or beverage containing a less than normal amount of sodium chloride which comprises adding to the said food or beverage a sodium chloride taste enhancing amount of a proteolysed protein source.
Patent PT-672677-E (PT)
Inventor: UHLMANN EUGEN
IPC: C07H21/04
Filed: 1995-03-08
Abstract: Polyamide-oligonucleotide derivatives (I) and their physiologically acceptable salts. Polyamide-oligonucleotide derivatives of formula F((DNA)-Li)q(PNA-Li)r(DNA-Li)s(PNA)t)xF' (I) and their physiologically acceptable salts are new. q, r, s, t = 0 or 1, with the sum of two or more adjacent letters at least 2; x = 1-20; DNA = nucleic acid (such as DNA or RNA or their known derivatives); Li = covalent linkage between DNA and PNA, i.e. a bond or a residue containing at least one atom of carbon, nitrogen, oxygen or sulfur; PNA = polyamide structure containing at least one nucleobase different from thymine; and F, F' = end groups and/or are connected through a covalent bond. Independent claims are also included for the following: (1) method for preparing (I); (2) pharmaceutical composition containing (I); and (3) gene probe assays for detecting oligo- or poly-nucleotide targets (RNA or DNA) in which (I) is used as probe and primer.
Patent PT-871473-E (PT)
Inventor: FERGUSON MARK WILLIAM JAMES
IPC: A61P17/00
Filed: 1996-08-08
Abstract: The present invention provides IL-10 or a fragment or a partially modified form thereof for use in promoting the healing of wounds and fibrotic disorders with reduced scarring and methods for same.
Patent PT-888601-E (PT)
Inventor: BRANDT THOMAS LYNN
IPC: G09F3/10
Filed: 1997-03-19
Abstract: The invention relates to a transfer label comprising a backing layer and a transfer layer which is releasably attached to the backing layer. From transfer to a container, the transfer layer is detached from the backing layer. After attachment to a container, the transfer layer can be removed in an aqueous liquid under turbulent soaking conditions at a temperature of not more than 100° C., preferably not more than 70° C. During these conditions, the transfer layer breaks up in at least four parts wherein each part is not smaller than 5 micrometers. The transfer layers is detached from the container with a soaking time of not more than 20 minutes, preferably not more than 10 seconds. The transfer label according to the present invention has a very high adherence during storage and use conditions, and can be rapidly removed from a container such as a reusable crate for bottles, in an economic manner.
Patent PT-892130-E (PT)
Inventor: COWPER BRIAN
IPC: E05B27/00
Filed: 1998-07-15
Abstract: A key-operable lock cylinder (2) comprises a rotor (4), a stator (6), a keyway (10) extending axially into the rotor (4) and a plurality of locking pins (16, 16'). The rotor (4) is mounted within the stator (6) for rotation about its axis and a plurality of transverse passageways (12) extend through the rotor (4) and the stator (6) and intersect the keyway (10). A pair of the locking pins (16, 16') are slidably mounted in each passageway (12) and the locking pins (16, 16') of a pair are resiliently biased so as to be in mutual abutment within the keyway (10) by a biasing means associated with each locking pin (16, 16'), such that one locking pin (16, 16') of each pair projects across an interface (22) between the rotor (4) and stator (6) so as to prevent rotation of the rotor (4). In use, when a complementary key (30) is inserted in the keyway (10), the locking pins (16, 16') are movable by the key (30) such that all the locking pins (16, 16') become located entirely within the rotor (4), so as to permit rotation of the rotor (4) (Fig 2). <IMAGE>
Patent PT-983508-E (PT)
Inventor: WILLIAMS RICHARD O
IPC: G01N33/53
Filed: 1998-03-11
Abstract: A method for the detection or quantitation of a water-borne parasite, such as Cryptosporidia. The detection or quantitation is accomplished by an electrochemiluminescence assay comprising the steps of filtering water to obtain a sludge thought to contain the parasite or a fragment thereof; extracting a sample of said sludge in a extraction medium to form antigenic derivatives of said parasite; forming an assay mixture comprising a sample of said extracted sludge and an antibody specific to said antigenic derivative; incubating said assay mixture to permit binding of said antibody and said antigenic derivative; and conducting an electrochemiluminescence assay for the bound complex of antibody and antigenic derivative, thereby detecting or quantitating the Cryptosporidia in said water.
Patent PT-1030838-E (PT)
Inventor: EISENBEIS SHANE ALLEN
IPC: C07D307/83
Filed: 1998-10-21
Abstract: A method for preparing pyrrole-carboxyamides which selectively bind to GABAa receptors; which comprises reacting 1,3-cycloakane-diones with bromoethylacetate followed by reaction of the resulting product with an acid halide followed by reaction with an aromatic amine and finally with an amonium source at an elevated temperature.
Patent PT-1027567-E (PT)
Inventor: DEDIEU BERNARD
IPC: F26B21/08
Filed: 1998-10-29
Abstract: involves pressurising wood and injecting water vapour before pressure reduction and dehumidifying. The wood drying method includes the following stages: - a pressure stage in which a set pressure is maintained in a sealed enclosure (1) by injection of a saturated water vapour and maintenance of the pressure for a set period of time, and ensuring forced air circulation with saturated water vapour; - a heating stage at the heart of the wood and in the central zone of the pieces of wood to be dried, by transmission of micro-waves in a frequency range from 400 to 2450 MHz; - an evacuation stage for the water running into the bottom of the enclosure (1), followed by a progressive reduction of the pressure to atmospheric pressure after the micro-wave radiation has stopped. The pressure reduction stage is completed by a dehumidifying of the ambient air in the enclosure, by passage of an air flow from the enclosure onto a humidity absorbing and air cooling system.
Patent PT-1047664-E (PT)
Inventor: ANDRIEUX JEAN
IPC: A61K31/381
Filed: 1998-12-11
Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m' are such as defined in the description; n represents an integer such that 0<=n<=3; p represents an integer such as defined in the description; B represents a group (a) or (b). The invention is useful for preparing medicines.
Patent PT-958745-E (PT)
Inventor: FRANCO MUTTI
IPC: A23C3/037
Filed: 1999-05-07
Abstract: A process for high-temperature sterilisation of produces such as milk and the like comprises the steps of directly injecting steam into the produce for heating it to a lower temperature than the sterilisation temperature, making the produce stand for a definite period of time, making the produce pass into an infuser to further heat it to the sterilisation temperature, keeping it to this temperature for a predetermined period of time, admitting the produce to a vacuum chamber for sudden cooling of same. A plant for application of the above process therefore comprises a steam injector (12), an accumulator for produce standing (13), an infuser (14) and a vacuum chamber (19), disposed in series. <IMAGE>
Patent SG-20488-G (SG)
Title: A packing laminate
IPC: B32B27/32
Filed: 1988-03-28
Abstract: A packing laminate for the manufacture of packing containers for edible oil must have an oil-resistant inner layer which is not affected by the oil, even during prolonged storage periods. A packing laminate meeting this condition has an extruded inner layer of two types of plastics mixed with one another, namely LLDPE and LDPE.
Patent IE-44758-L (IE)
Title: Indanes.
IPC: C07C59/84
Filed: 1977-01-10
Abstract: 5-Substituted indan-2-carboxylic acids and functional derivatives thereof having inflammation-reducing properties have the general formula <IMAGE> in which R is a phenyl, phenyl-lower alkenyl, phenyl-lower alkyl, phenyl substituted by at least one of the halogens, lower alkyl, lower alkoxy, acetamido, amino, lower dialkylamino, nitro, phenyl, lower alkylsulfonyl, lower dialkylaminosulfonyl and sulfamido, cyclohexyl, furyl, lower alkylfuryl, thienyl, halothienyl, lower alkylthienyl, or pyridyl group and R' is a hydroxyl, lower alkoxy, lower dialkylaminoalkoxy, cinnamoylamido lower alkoxy, 2-hydroxyethylamino, amino or lower dialkylaminoalkyl amino group. Besides the esters and amides, the functional derivatives of the acids include the pharmacologically acceptable salts of the above compounds. The compounds are also of low toxicity, have analgesic activity and exert an antipyretic effect.
[US4269848A]
Patent IE-31846-L (IE)
Title: Liquid detergent compositions
IPC: C03B37/02
Filed: 1968-01-22
Abstract: 1,205,711. Liquid detergent compositions. UNILEVER Ltd. 24 Jan., 1968 [27 Jan., 1967], No. 3736/68. Heading C5D. A substantially non-aqueous built liquid detergent composition comprises 20-90% by weight of one or more liquid detergent active materials, 1-70% of one or more anhydrous inorganic builder salts and 0.1 to 10% of an inorganic carrier material which has a particle size of 1-100 mÁ, a bulk density of 10-180 g/l. and an average surface area of 50-500 m2/g. The carrier may be silica, alumina, magnesia and/or ferric oxide. Preferred detergent active materials are non- ionic detergents obtained by introducing watersolubilizing polyoxyalkylene groups into alkyl phenols, aliphatic alcohols, carboxylic acids and polyoxyalkylenes, to give molecular weights of about 300-11,000. The detergent active material may also be a mixture of non-ionic detergent active materials or a mixture of a non-ionic detergent active material with one or more other detergent active materials, such as anionic, cationic and ampholytic detergent active materials and soap, provided that the final composition is a liquid. Specified builders are anhydrous alkali metal poly-, pyro- and meta-phosphates, silicates, borates, carbonates and sulphates. Bleaching agents such as sodium perborate, percarbonates, and persulphates may also be added. Also up to 10% of a thinning agent may be added to reduce the viscosity, such as ethyl alcohol, hexane, heptane, benzene, xylene, toluene, cyclohexane, tetrahydrofuran, dimethyl sulphoxide, or dimethyl formamide. Additional ingredients which may be present are enzymes, colouring agents, fluorescers, bleaching agent precursors, bleaching agent stabilizers, perfumes, bactericides, soil-suspending agents, sequestering agents and hydrotropes (e.g. sodium toluene sulphonate or sodium xylene sulphonate).
[GB1205711A]
Patent IE-870135-L (IE)
Title: Measuring of antigens and antibodies
IPC: G01N33/548
Filed: 1987-01-20
Abstract: A method for measuring the level of circulating antigen (Ag1), antibody (Ab1) or hapten (H) in a liquid sample, which comprises forming in a liquid phase reaction a soluble complex wherein said antigen (Ag1) antibody (Ab1) or hapten (H) is linked through, respectively, a specific antibody (Ab), antigen (Ag) or antihapten (Anti-H), to a matrix which is soluble in the liquid phase and carries a ligand (X), subsequently forming an insolubilised complex comprising a solid support linked to the ligand (X) of said soluble complex through an anti-ligand (Y), the insolubilised complex carrying a label (Z) linked to the antigen (Ag1) through an anti-antigen (Anti-Ag1), to the antibody (Ab1) through an anti-antibody (Anti-Ab1) or to the hapten (H), washing the insolubilised complex, and checking the washed insolubilised complex for the presence of the label (Z) to provide a measure of the level of said antigen (Ag1), antibody (Ab1) or hapten (H) in said sample.
Patent IE-38781-L (IE)
Title: Oestrogen treatment pack
IPC: A61J7/04
Filed: 1974-01-24
Abstract: 1459485 Pharmaceutical packs CIBAGEIGY AG 11 Feb 1974 [13 Feb 1973] 06134/74 Heading A5B A pharmaceutical treatment pack for oral treatment with oestrogen, especially for treatment of the climacteric syndrome, comprises a container, card or other support member in or on which there are arranged two or more sets of 5 dosage unit oestrogen-containing preparations suitable for oral administration to a human female and two or more sets of 2 dosage unit oestrogen-free preparations or of objects indicating no oestrogen treatment, the sets being located in a particular order, together with indications and/or instructions to indicate and facilitate a treatment extending over two or more consecutive periods of 7 days consisting, of the oral administration of one of the oestrogen-containing dosage unit preparations on each of the first five successive days of every 7-day period and the administration on the last two days of every such period of an oral, but oestrogenfree, dosage unit preparation or no preparation. The oestrogenfree preparation may 'be a placebo. Oestrogens mentioned are the "conjugated oestrogens" (mixture of sulphates of oestrone, e.g. equiline, equilenine and of the corresponding 17- hydroxy compounds generally obtained in the form of sodium salts from the urine of pregnant mares), 1α-ethyl osetrone, oestriol and oestradiol valerate.
[GB1459485A]
Patent IE-840174-L (IE)
Title: Liquid pesticidal agent.
IPC: A01N47/30
Filed: 1984-01-26
Abstract: The aqueous mixed dispersions, according to the invention, of pesticides, which contain an active compound concentrate, based on (C1-C12)-alkyl phthalates as the solvent, of one or more active compounds melting below 70 DEG  C., in combination with an aqueous suspension concentrate of one or more active compounds melting above 70 DEG  C., possess surprisingly high stability on storage.
Patent IE-870277-L (IE)
Title: 5-substituted octahydroindolizines
IPC: C07D471/04
Filed: 1987-02-03
Abstract: Octahydroindolizidines and corresponding ketones of the formulae (I) and (II):wherein. A is a 3-7 carbon or hetero-containing ring, R' is a substituent, n is 0-6 and x is 0-3. Also, pharmaceutical compositions for treating pain containing (II or (II) and methods for synthesis and use as well as novel intermediates in the synthesis.
Patent IE-780328-L (IE)
Title: Stabilisation of anhydrous sodium metasilicate.
IPC: C11D3/08
Filed: 1978-02-15
Abstract: Anhydrous sodium metasilicate is stabilized against attrition or "dusting" in detergent and other use, by formulating same with such amount of an additive, e.g., a hydrate, that will transfer water content to the anhydrous metasilicate, at a temperature less than the fusion temperature of sodium metasilicate pentahydrate and as will convert from about 1% to 20% by weight of said anhydrous metasilicate into its pentahydrate form.
[US4289643A]
Patent IE-42511-L (IE)
Title: Press for deformable tube
IPC: B65D35/28
Filed: 1976-03-12
Abstract: Tube squeezing device for deformable tubes of the type containing soft paste, comprising two jaws pivotally connected to each other, each jaw comprising a squeezing cylinder, the tube to be squeezed being held between the two cylinders, and means for providing the rotation of one of the squeezing cylinders thus determining the advancing of the device along the tube. Means being provided for preventing the moving back of the device over the squeezed part of the tube; and further means for providing the disengagement of the tube from the device.
[US4030636A]
Patent IE-780705-L (IE)
Title: Benzimidazole-2-thiones.
IPC: A61K31/4184
Filed: 1978-04-11
Abstract: Benzimidazole derivatives of the formula <IMAGE> in which R and R1 independently of one another are each hydrogen, an alkanoyl group having 1 to 4 carbon atoms, an alkoxycarbonyl group having 1 to 4 carbon atoms, an alkylsulphonyl group having 1 to 4 carbon atoms, a benzoyl group, a phenylsulphonyl group or a p-methylphenylsulphonyl group; R2 and R4 independently of one another are each hydrogen, halogen or a methyl group, R3 is hydrogen, halogen, a methyl group or a methoxy group; X is oxygen or sulphur; Y is halogen, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a methylthio group, a methylsulphinyl group, a methylsulphonyl group, a trifluoromethyl group, a nitro group, a hydroxyl group, a cyano group or an acetyl group; and m is 0, 1, 2 or 3; and if one of the two radicals R or R1 is hydrogen, the position of the other of these radicals on the N atoms cannot be clearly established, including, when at least one of the two radicals R or R1 is hydrogen, the possible tautomeric compounds of the formula I; and the disulphides obtainable by oxidation of compounds of the formula I. The compounds are useful for combating helminths in domestic animals and productive animals.
[US4205077A]
Patent IE-800838-L (IE)
Title: Di- and tetra peptides
IPC: C07K1/06
Filed: 1980-04-25
Abstract: A method for solution synthesis of H-SAR-LYS-SAR-GLN-NH2 in good yield and compositions useful therein are disclosed.
[EP0018793A2]
Patent IE-820866-L (IE)
Title: Checking the operating conditions of a flow and pressure¹control member
IPC: G01M3/28
Filed: 1982-04-14
Abstract: An apparatus and method for checking the operation of a fluid flow and/or pressure control member with a given and constant flow, wherein the control member is disposed at the outlet of a main fluid circuit connected to a source of pressurized fluid and a bypass circuit at its inlet and having a fluid bleed circuit with an isolation device at its outlet upstream from the control member. The main circuit includes a flow meter, a pressure meter, a progressive volume variation member to enable the pressure in the main circuit to be varied gradually and without fluctuations, and isolation devices for isolating the volume variation member from the control member and for isolating the inlet of the main circuit from the fluid source and the bypass circuit. Electrical comparators, triggered at different times in response to the actuation of different ones of the components of the apparatus are employed for comparing the pressure in the main circuit with reference pressures for checking the operation of the control device.
Patent IE-44927-L (IE)
Title: Lysolecithin-type pharmaceutical compositions
IPC: C07F9/10
Filed: 1977-05-03
Abstract: HOE 76/S 005 TUMOR ANTIDOTE of the disclosure: The present invention provides tumor antidotes consisting of or containing a short chain synthetic lysolecithin analog.
[CA1094455A]